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Objective: To study whether patients with HIV-1 associated lipodystrophy (LD) on highly
active  antiretroviral treatment (HAART) have more psychopathology and worse psychosocial
adjustment  than a similar group without this syndrome.
Methods: In a cross-sectional, observational study we compared 47 HIV-1 infected patients
with  LD (LD group) with 39 HIV-1 infected patients without LD (non-LD group). All par-
ticipants  were on HAART. The Beck Depression Inventory (BDI), the State and Trait Anxiety
Inventory  (STAI) and the Goldberg Health Questionnaire (GHQ-60) were  administered. Levels
of  familial, work and social adjustment and adjustment to stressful events were evaluated
in  a semi-structured interview. Clinical information was extracted from the clinical records.
Results:  In the univariate analysis patients with LD showed higher state anxiety scores
(p  = 0.009) and worse work adjustment (p = 0.019) than those without LD. A total of 45.3%
of  LD patients scored above the cut-off point on the trait anxiety scale, and over 33.3%
scored  above the cut-off point on the BDI, GHQ and state anxiety scales. However, in multi-
variate  analyses LD was not independently associated with psychopathology or with worse
adjustment  in the studied areas.
Conclusions: The ﬁnding that LD was not a predictor of greater psychopathology or worse
psychosocial  adjustment in HIV-1 infected patients, despite the high scores found, suggeststhat factors not taken into account in this study, such as LD severity and self-perception
should  have been included in the analysis. Further studies including a greater number of
variables and a larger sample size will advance our understanding of this complex condition.
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© 20HIV mortality and morbidity have decreased dramatically
since the availability of HAART,1 but as life expectancy
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Este é um artigo Open Access sob a licençaincreases new metabolic complications have emerged. One
of  these complications is lipodystrophy (LD), also referred
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDl Medicine Service, C. Sant Antoni Ma Claret 167, 08025 Barcelona,
to  as the HIV-lipodystrophy syndrome or fat redistribution
syndrome. It was ﬁrst described in 19982 but no standard deﬁ-
nition  has yet been described. LD involves elements related to
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etabolic disorders and redistribution of body fat. The most
mportant  clinical feature is the fat loss (lipoatrophy) from the
ace,  limbs and buttocks, sometimes with central fat accu-
ulation  on the abdomen, breasts and dorso-cervical spine.
hese  body changes, especially those in the face, are the most
requent  and distressing signs of this clinical syndrome.
Patients perceive body changes, especially facial lipoa-
rophy, as a stressful and disﬁguring symptom of their
isease.3,4 They fear that fat loss represents progression of the
isease  and worry that visible changes may  lead to uninten-
ional  disclosure of their HIV status.5 Consequently, physical
anifestations of LD affect self-esteem, self-image and self-
erception,  and increase feelings of stigmatization.3,6,7 This
n  turn may  cause psychological distress and negatively affect
ocial,  professional and sexual relationships,3,5,7 leading to
imited  participation in physical activities, poor social func-
ioning,  loneliness and isolation.4,7,8
Psychopathology and psychosocial adjustment has been
tudied  previously but ﬁndings are controversial. Collins et al.3
nd Power et al.,7 for example, investigated quality of life and
sychosocial adjustment in HIV-1 positive patients with LD
nd  found that anxiety and depression were higher than in
on-LD  patients. On the other hand, Preau et al.9 found LD
o  be independently associated with depression but not with
nxiety.  However, Steel et al.10 studied the effects of LD on
uality  of life and depression in HIV-infected men  on HAART
ut  did not ﬁnd any association between LD and depression.
uch  of this controversy may  be due to differences in popula-
ion  samples and methodologies: study samples were mainly
mall  and non-homogenous, and the methods used varied
rom  qualitative to quantitative approaches.
Psychopathology and psychosocial adjustment in HIV
nfected  patients with LD compared to those without LD there-
ore  remains unclear. Furthermore, no studies have yet been
erformed  using validated tools in the Spanish population.
The  purpose of this study was  to determine whether psy-
hopathology and psychosocial adjustment in HIV-1 infected
atients  on HAART who developed LD differed from HIV-1
nfected  patients without this syndrome.
aterials  and  methods
e  conducted a cross-sectional study of patients receiving
are  at our department. The study was  carried out in the Infec-
ious  Diseases Unit and the Psychosomatic Unit at the Hospital
e  la Santa Creu i Sant Pau, Barcelona.
All HIV positive patients on HAART receiving care at the
utpatient service were invited to participate in the study.
he  objectives of the study were explained and patients
ho  signed the informed consent were  referred to the study
sychologist. During the interview with the psychologist all
nclusion  and exclusion criteria were reviewed. The study was
pproved  by the institutional ethics committee. Participants’
nonymity and conﬁdentiality were  ensured at all times.
The  study population included literate female and male
atients, 18 years and older, who  were HIV-1 infected and on
AART. We  excluded patients without the necessary Spanish
anguage  skills to answer the questionnaires and those who
ad  any physical, psychiatric or cognitive disorders that could3;1 7(4):444–449  445
interfere  with their participation in the study, or compromise
the  reliability of the self-reported measures. We also excluded
patients  with missing data.
Ninety per cent of patients agreed to participate in the
study  and signed the informed consent form. The sample
consisted of 86 patients: 47 clinically evident LD and 39 non-
LD  patients. As there is no objective, validated, sensitive
and  speciﬁc case deﬁnition of HIV-associated LD,2 the LD
syndrome was  considered present when both physician and
patient  agreed that signs and symptoms of the disorder were
present.11
The psychologist conducted a semi-structured inter-
view  where data related to sociodemographic factors were
obtained.  Psychological tests (GHQ, BDI, STAI) were self-
administered and clinical variables were abstracted from
medical  records.
Demographic  characteristics
Demographic variables collected were age, gender, cohabita-
tion  status, number of years living outside country of birth if
immigrant,  educational level, profession and employment sta-
tus. Participants were  asked about familial, work and social
adjustment, adjustment to stressful events, and perceived
familial and social support in order to establish their psy-
chosocial adjustment. Questions were as follows: “Are you
satisﬁed  with your adjustment to new life situations?” “Are
you  satisﬁed with your social adjustment?” “Are you satis-
ﬁed  with the support of your friends?” All questions were
open-ended: “yes” (indicating adjustment) or “no” (indicating
maladjustment).
The  General  Health  Questionnaire  (GHQ)
The General Heath Questionnaire12 evaluates general mental
health.  It has been used by other authors in studies in HIV
infected  patients.13,14 In this study we used the Spanish vali-
dated  version of this questionnaire.15 It was  self-administered
and scores above 11 were  considered pathological.
The  Beck  Depression  Inventory  (BDI)
The Beck Depression Inventory16 assesses depression on a 21-
item  scale. In positive cases, it also evaluates severity and
intensity  of the symptomatology. It has been successfully used
in HIV infected patients in previous studies.17–20 In this study
the  Spanish validated version was used.21 The questionnaire
was self-administered and scores of 10 or above were consid-
ered  indicative of depression.
The  State  and  Trait  Anxiety  Inventory  (STAI)
Anxiety was assessed by using the State and Trait Anxiety
Inventory.22 This tool is composed of two scales, “State anxi-
ety”  that describes feelings indicative of current anxiety, and
“Trait  Anxiety” which describes feelings indicating normal
anxiety.  Both scales have 20 items and the answers to all items
are  scored from 0 (no anxiety) to 3 points (highest anxiety).
Scores were transformed into percentiles and those above the
55th  percentile were considered pathological. We  used the
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Table 1 – Sociodemographic and clinic characteristics of
LD  and non-LD groups [n = 86; *p < 0.05].
Variables LD
(n = 47)
No LD
(n = 39)
p-Value
Age [mean (SD)] 44.17 (6.95) 41.5 (8.02) 0.097
Male gender [n (%)] 41 (87.2) 28 (71.8) 0.103
Cohabitating [n (%)] 32 (37.2) 14 (35.9) 1.00
Immigrants [n (%)] 20 (42.61) 9 (23.1) 0.069
Years away from home
[mean  (SD)]
14.43 (18.60) 4.59 (10.61) 0.003*
Educational level 0.204
University studies
[n  (%)]
6 (12.8) 10 (25.6)
High school [n (%)] 18 (38.3) 16 (41)
Primary school [n
(%)]
23 (48.9) 13 (33.30)
Profession 0.464
Housework [n (%)] 4 (8.5) 3 (7.70)
Not qualiﬁed [n
(%)]
25 (53.2) 18 (46.2)
Qualiﬁed [n (%)] 14 (29.8) 10 (25.6)
Specialist [n (%)] 4 (8.5) 8 (20.5)
Presently employed [n
(%)]
29 (61.7) 27 (69.23) 0.503
Years since HIV-1
infection  diagnosis
[mean  (SD)]
11.19 (4.392) 9.23 (5.269) 0.068
Years on HAART
[mean  (SD)]
6.37 (2.07) 5.56 (4.00) 0.065
CD4 [cels/mm3] [mean
(SD)]
680.79 (342.42 592.36 (343.71) 0.154
Viral load
[log  copies/mL]
[mean  (SD)]
2.34 (1.19) 1.77 (0.66) 0.037*
Mode of HIV
acquisition
0.588
Parenteral drug
use  [n (%)]
6 (12.8) 4 (10.3)
Heterosexual
intercourse [n (%)]
16 (34) 12 (30.8)
Homosexual
intercourse [n (%)]
19 (40.42) 13 (33.3)
Table 2 – Level of psychosocial adjustment of both
groups [n = 86; *p < 0.05].
Variables LD patients
satisﬁed
n  (%)
No  LD patients
satisﬁed
n  (%)
p-Value
Familial
adjustment
39 (83) 33 (84.6) 1.000
Work adjustment 38 (59.6) 33 (84.6) 0.019*
Social
adjustment
32 (68.1) 31 (79.5) 0.328
Adjustment to
stressful
events
36  (76.6) 36 (92.3) 0.077Accidental [n (%)] 0 (0%) 1 (2.6%)
Unknown [n (%)] 6 (12.8%) 9 (23.1%)
Spanish validation carried out by Bermúdez23 Several authors
have  used this inventory in HIV studies.24,25
Clinical  variables
Data related to HIV infection and clinical status were also
recorded.  These variables included years since HIV-1 diagno-
sis,  years on HAART, CD4 counts (cels/mm3), plasmatic HIV
viral  load (log copies/ml), and mode of HIV acquisition.
Statistical  analyses
Means and standard deviation (SD) were  obtained for quanti-
tative  variables and percentage and frequencies for categorical
data.  The Student t-test was  used to compare quantitative
variables between groups (with and without LD). The cor-
rected  results were  used to avoid possible heteroscedasticity.Familial  support 40 (85.1) 32 (82.1) 0.774
Social support 39 (83) 35 (89.7) 0.522
Fisher’s exact test was  used to compare categorical values. A
logistic regression model using a forward procedure was  used
to  predict the presence of psychopathology. The dependent
variables were psychopathology (measured with the GHQ),
trait  anxiety and state anxiety (estimated with the STAI), and
depression  (evaluated with the BDI). The independent vari-
ables  were LD, educational level, employment status, familial
adjustment, social adjustment, work adjustment, adjustment
to  stressful events, profession and the questions asked in the
interview.
A  bilateral approach was  used for all calculations and the
probability of a type I error was  5% (  ˛ = 0.05). Values of p < 0.05
were  considered signiﬁcant. All the analyses were  done using
the  SPSS statistical package v 14.0.
Results
Ninety-six patients were  approached and 90% (n = 86) agreed to
participate in the study. All participants gave written informed
consent.  Mean age was  42.9 (range: 24–62) years and 80.2%
were  men. Those with LD were  on average three years older
than  non-LD patients (p = 0.097) but differences were  not sig-
niﬁcant.  A total of 39.5% of the participants had completed
high  school, 65.1% were presently employed and 27.9% were
qualiﬁed  workers. More than 33% were immigrants. The per-
centage  of immigrants was  almost 20% higher in the LD group
(p  = 0.069) but this was not statistically signiﬁcant.
HIV infection was mainly transmitted by sexual inter-
course and no “mode of acquisition” differences were found
between  groups. Patients with LD showed statistically sig-
niﬁcant  higher values of viral load (p = 0.037). No statistical
differences were  found between LD patients who  were diag-
nosed  some years earlier (p = 0.068) and were  on HAART
regimen for a longer period (p = 0.065) and non-LD patients.
Sociodemographic and clinical variables are shown in Table 1.
When studying psychosocial adjustment (detailed results
in  Table 2), LD patients referred worse work adjustment
(p  = 0.019) as compared to non-LD patients.
Psychopathologic  resultsThe mean score of the GHQ test for the total sample was
11.40  (SD 13.36); one-third of participants scored above the
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Table 3 – Detailed scores of the administered
questionnaires [n = 86; *p < 0.05].
Variables LD score
Mean  (SD)
No  LD score
Mean  (SD)
p-Value
GHQ 12 (13.14) 10.67 (13.77) 0.644
BDI 9.28 (9.857) 8.36 (7.586) 0.100
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Table 5 – Logistic regression analysis of
psychopathological variables [n = 86; *p < 0.05].
Variables B coef p-Value OR
GHQ
Being unemployed 2.39 <0.001* 11.015
Maladjustment to
stressful  events
3.64  <0.001* 38.39
BDI
Social
maladjustment
1.53 0.013* 4.65
Maladjustment to
stressful  events
2.75 <0.001* 15.71
State  anxiety
Maladjustment to
stressful  events
1.67  0.011* 5.34
Trait anxiety
Social
maladjustment
1.66  0.011* 5.26State anxiety 41.72 (29.765) 34.33 (25.52) 0.219
Trait anxiety 53.77 (34.038) 44.62 (31.73) 0.201
ut-off point. No statistically signiﬁcant differences were
btained  between groups. Multivariate analyses showed that
eing  unemployed (p < 0.001) and “maladjustment to stress-
ul  events” (p < 0.001) were  predictors of scores above the GHQ
hreshold  criteria.
The  mean score on the BDI for the total sample was  8.86 (SD
.86).  More  than 30% of patients scored above the cut-off point,
nd  no statistically signiﬁcant differences were  seen between
roups  either when comparing pathological scores (p = 0.518)
r  mean scores (p = 1). Multivariate analyses of BDI showed
hat  “social maladjustment” (p = 0.013) and “maladjustment to
tressful events” (p < 0.001) were  predictors of psychopatholo-
ical  scores.
The  mean score in the state anxiety scale was  within the
8.37  percentile (SD 28.0). Pathological scores were observed
n  27.9% of cases. LD patients showed higher statistically sig-
iﬁcant  pathological scores (p = 0.009) than non-LD patients.
he  logistic regression analyses showed that “maladjustment
o  stressful events” (p = 0.011) was  a predictor of a higher state
nxiety  score.
In  the trait anxiety scale the mean score was  in the 49.62
ercentile and the SD was  33.14. Scores were above the cut-off
oint  in 45.3% of patients. We  observed no statistically signif-
cant  differences between groups (p = 0.131). When combining
he  variables in the logistic regression model, “social malad-
ustment”  (p = 0.011) and “maladjustment to stressful events”
p  = 0.035) were predictors of higher trait anxiety score.
The mean scores on the questionnaires are summarized
n Table 3. The percentage of pathological scores on each
uestionnaire is shown in Table 4. Finally, the predictors of
sychopathology are described in detail in Table 5.
iscussionn the current study we found that HIV-1 infected patients with
D  had non-signiﬁcantly higher pathological scores in the psy-
hopathology questionnaires than non-LD patients. Scores for
Table 4 – Patients with pathological results of the
administered questionnaires [n = 86; *p < 0.05].
Variables LD patients with
pathological
scores
n (%)
No-LD patients
with  pathological
scores
n  (%)
p-Value
GHQ 17 (36.2) 13 (33.9) 0.825
BDI 10 (21.3) 7 (17.9) 0.518
State anxiety 17 (36.2) 7 (17.9) 0.009*
Trait anxiety 25 (53.2) 14 (35.9) 0.131Maladjustment to
stressful  events
2.33  0.035* 10.34
all tests were  higher in both groups than scores reported in the
literature  for the general population.26,27
The GHQ scores for the total sample were  pathological
according to the aforementioned threshold criteria. These
results  are in line with many  ﬁndings in the literature.13,14
When we  compared the differences in psychopathology in
LD  and non-LD groups neither the mean scores nor the per-
centages  of positive test scores were signiﬁcantly different
between groups. A more  speciﬁc questionnaire would perhaps
reveal  psychopathological traits in LD patients that are not
captured  by the GHQ. Interestingly, patients with positive GHQ
scores showed that “being unemployed” and “maladjustment
to  stressful events” were  predictors of pathological scores in
the GHQ in the multivariate analysis. This is in agreement with
previous  results from Lyketsos et al.18 and Hays et al.28 who
found  that being unemployed was  a predictor of depression in
HIV-1 infected patients.
Before  HAART, the prevalence of depression in HIV-1
infected patients was reported to be much  higher than in the
general  population, as stated by Lyketsos et al.18 and Judd
et  al.19 After 1996, HIV disease became treatable thanks to
the  availability of protease inhibitors, and the prevalence of
depression  decreased.20 Our results support these changes as
the prevalence of depression was  lower than that reported by
Lyketsos et al.18 and Judd et al.19 We  did not ﬁnd any signiﬁcant
difference when comparing LD and non-LD patients, as stated
by  others.9 Authors such as Collins et al.3 and Power et al.7
suggest a relationship between LD and depression but these
studies  did not use validated instruments and depression
was recorded only as a symptom. In our multivariate anal-
ysis  “social maladjustment” and “maladjustment to stressful
events”  were positive predictors of pathological BDI  scores, as
reported previously by de Ridder et al.29 and Fehr et al.30
More than one-third of the total sample scored above the
threshold  criteria on both STAI scales, with the LD group
showing higher values and higher percentages of patholog-
ical  results than non-LD patients. Studies using the STAI to
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compare HIV-1 infected patients with the general population
have  found higher scores in the former but none of these
reviews included LD patients.24 Power et al.7 performed a
study  with a small number of HIV-1 infected patients with LD
using a semi-structured interview and found that fat redis-
tribution  was  a predisposing factor for greater anxiety. Our
analysis  showed that “social maladjustment” and “maladjust-
ment  to stressful events” were  predictors of pathological trait
anxiety scores, while “being unemployed” and “maladjust-
ment to stressful events” were  predictors of pathological state
anxiety scores. In our multiple regression model LD was  not a
predictor of trait anxiety or state anxiety. Although LD was  not
the  most powerful predictor of anxiety, more  detailed analy-
ses  in larger samples may  reveal stronger associations since
the  whole HIV-1 sample had higher anxiety state scores than
general  population.
One  of the limitations of this study is that it attempts to
evaluate  psychological aspects of a very complex syndrome.
Our  sample was  small and we  were unable to draw conclu-
sions  for subgroups of gender, age or LD severity. It should also
be  mentioned that the study was  conducted in the outpatient
service  of a 600-bed tertiary university hospital in a cosmopoli-
tan  city where stigmatization concerning HIV infection has
notably  decreased in recent years. The sample is therefore not
a  true representation of the HIV community in our country as
we did not include patients from smaller towns or rural areas
where  HIV infection and fat redistribution would perhaps have
a deeper psychological impact due to higher stigmatization. A
ﬁnal limitation of this study is that we did not have a control
group  from the general population.
In conclusion, LD causes body disﬁgurement and has a pro-
foundly  negative impact on the psychological wellbeing and
on  the psychosocial adjustment of those affected. Although
we  did not ﬁnd statistically signiﬁcant differences between
the  two groups we  think this is likely because variables such us
LD severity, self-perception, gender and age were not included
in  the analysis. Studies with larger samples sizes are needed
to  better deﬁne the relationship between this very complex
syndrome and its real psychological repercussions.
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